Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
Investors are buzzing about great news amazon stock as Amazon leans into cloud, ads, and AI. This guide explains the ...
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
A sharp, fear-driven decline hit Microsoft, but a deeper look suggests the selloff may reflect sentiment more than so...
Disney has debated separating its Parks division as the media world reshapes itself. This article explains whether a ...
Citigroup stands out as the bank watchers' proxy on a rare earnings day for the big five. Markets look for signs on l...
A Thursday rally put Oklo in the spotlight after a strategic supply agreement. This piece breaks down what happened, ...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
As August approaches, a key SpaceX catalyst coming could shift the balance for investors. This guide breaks down what...